Literature DB >> 22668595

Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa.

C C Bristow1, E Larson, A K Vilakazi-Nhlapo, M Wilson, J D Klausner.   

Abstract

We reviewed the implementation of isoniazid preventive therapy (IPT) in South Africa from January 2010 to March 2011. The South African National Department of Health distributed revised IPT guidelines in May 2010 to increase IPT use in eligible human immunodeficiency virus (HIV) infected patients. We found a dramatic increase in the absolute numbers of patients reported to have been initiated on IPT (from 3309 in January-March 2010 to 49 130 in January-March 2011), representing an increase in the proportion (1.0-10.5%) of potentially eligible HIV-infected patients started on IPT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668595     DOI: 10.5588/ijtld.11.0744

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

Review 1.  Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

Authors:  Molebogeng X Rangaka; Solange C Cavalcante; Ben J Marais; Sok Thim; Neil A Martinson; Soumya Swaminathan; Richard E Chaisson
Journal:  Lancet       Date:  2015-10-26       Impact factor: 79.321

2.  Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy?

Authors:  Stephen D Lawn; Robin Wood
Journal:  Int J Tuberc Lung Dis       Date:  2012-08       Impact factor: 2.373

3.  Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa.

Authors:  Divya K Chandra; Anthony P Moll; Frederick L Altice; Elizabeth Didomizio; Laurie Andrews; Sheela V Shenoi
Journal:  Glob Public Health       Date:  2021-03-02

4.  The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Authors:  Gwenan M Knight; Gabriela B Gomez; Peter J Dodd; David Dowdy; Alice Zwerling; William A Wells; Frank Cobelens; Anna Vassall; Richard G White
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

5.  Views of Medical Doctors Regarding the 2013 WHO Adult HIV Treatment Guidelines Indicate Variable Applicability for Routine Patient Monitoring, for Their Family Members and for Themselves, in South-Africa.

Authors:  Willem Daniel Francois Venter; Lee Fairlie; Charles Feldman; Peter Cleaton-Jones; Matthew Chersich
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

6.  Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.

Authors:  Liesl Page-Shipp; James J Lewis; Kavindhran Velen; Sedikanelo Senoge; Elizabeth Zishiri; Flora Popane; Violet N Chihota; Dave Clark; Gavin J Churchyard; Salome Charalambous
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

Review 7.  Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.

Authors:  Lisa V Adams; Elizabeth A Talbot; Karen Odato; Heather Blunt; Karen R Steingart
Journal:  BMC Infect Dis       Date:  2014-05-21       Impact factor: 3.090

8.  Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa.

Authors:  Oladele Vincent Adeniyi; Nonkosi Selanto-Chairman; Eyitayo Omolara Owolabi; Anthony Idowu Ajayi; Dominique Kabengele Kayembe; Daniel Ter Goon; Avramovic Gordana; John Lambert
Journal:  BMC Public Health       Date:  2019-10-29       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.